anonymous
Guest
anonymous
Guest
slow board.....
Announced today -- EC acquired by BSX at $210 valuation.......or $8 per share
Announced today -- EC acquired by BSX at $210 valuation.......or $8 per share
Smart buy by BSX, but they'll still have their hands full trying to push this tech.
That said, now they'll have a full line, and some scopes to play with. Can't believe they bought it for so little... how bad of shape was this company in??
No surprises. In typical CHIE fashion, GC tells us that no job is safe. Look, I get it, we were acquired but just once, can this guy realize that we are people, with families, and are stressed out by this development. Does he always have to a be a non caring douche?
Haters gonna' hate.
Sounds like jealousy.
Haters gonna' hate.
Sounds like jealousy.
You people are a bunch of pussies. Truly. PUSSIES. MG blew a huge opportunity to make EC something really big but he just failed to execute. He had too many of the wrong people on the bus. But you know what he did? He built a company from nothing and took it to an IPO on the NYSE. He raised hundreds of millions of dollars. Round after round. And then he sold the company for $210 million just 8 years later. That, my friend, is and example of "the man in the arena". And you haters are the poor, timid souls that know neither victory nor defeat.
For every 10 investments that a VC like Deerfield makes, they know 6 will fail and they'll get zero return, 2 at 3 return, and 2 at 10X. It's part of the game. Feel sorry for the investors? Are you f---ing serious? Everybody knows the game and the risks.
And how did you people NOT know that the writing was in BOLD PRINT on the wall, in like 5000 font? Where did you think they were going to get more money? There were 2 directions in the last 6 months: 1) Raise more money (which they couldn't and it was well known that they were failing at that) and 2) Exit via strategic sale. How the hell did you not see that?
Did MG squander an opportunity? I definitely think so. So many mistakes with personnel, direction, messaging, accountability, etc. I'm not sure how much equity he took off the table at the IPO- most VCs are good with a modest cash out. He left with a little over $6 million. But he built a company from zero to $210m valuation in 8 years. That's not too shabby.
Having said that, there's no way in hell I'd ever work for anything he does in the future. EC was a toxic waste-dump. It's culture and work-force engagement was horrendous. But that SOB at least was in the arena and you pussies weren't.
The deal makes sense & then again, it doesn't. They can bypass the shit products like mako & pretty much all devices w/exception of esophageal stents & Rescue. They already have products in those areas.
Gilreath never wanted to really compete with Boston Sci. That is why he never had any ERCP products. And obviously never gave a shit about making a quality forceps, bander, needle etc.
He knew he couldn't compete with Olympus too, really. But he knew that if he didn't overlap too much with Boston, it would be more complementary and more attractive for Boston to purchase EC.
Good for him, but what he told the people working there was bullshit. They were never really looking to change Endo. He was always looking for Boston or someone else to do that.
Boston adds the compliance stuff to their contracts.
They get a presence in pathology of they decide to keep that part.
And they have scopes now. The scopes make sense with Boston Sci.
The price does not make sense unless there are some restrictions on how one company has to purchase another. They could have gotten a much better deal. Really pricey. Even when you consider it is a price less than half of what it was in Jun 16.
For the record, the place was a shit show. But what rapidly growing company isn't?
Please stop talking. It's clear you don't know what you're talking about.
For the record, Boston actually wants the Rescue family of products as well as the needle. The interject needle from BSC needed a face lift 5 years ago.
As far as scopes go...BSC doesn't want them or have the bandwidth to sell them. It's easier for them to sell it off to a company that will actually do something with it.
I think the guy was saying the devices suck except rescue, which, by the way is spot on. So you are saying they paid this exhorbitant price just to aquire rescue & will sell the scope business? Why the hell would they do that? Who would they sell the scope business to? Who else has a presence in GI to sell the product?
Yeah, interject sucks, but is EC's needle any good? It's not like EC has any device technology that is an improvement over anything else on the market. Didn't EC originally just purchase some other crappy company's device line & modify it a little?